Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Once-daily versus twice-daily lopinavir/ritonavir with tenofovir and emtricitabine during Ramadan in adults with HIV infection
PACTR201007000226131Not yet recruiting
- Sponsor
- Dr. Habib AG
- Start
- Jul 2010
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Trial of lopinavir, ritonavir, tenofovir and emtricitabine in human immunodeficiency virus infection (HIV) (2 arms), sponsored by Dr. Habib AG. Planned start Jul 2010; status: not yet recruiting.
02
Drugs
lopinavirritonavirtenofoviremtricitabine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on PACTR201007000226131.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201007000226131.